Omeros's average Accounts Receivable for the
three
months ended in Dec. 2023 was $6.72 Mil. Omeros's Revenue for the
three
months ended in Dec. 2023 was $0.00 Mil.
The historical rank and industry rank for Omeros's Days Sales Outstanding or its related term are showing as below:
During the past 13 years, Omeros's highest Days Sales Outstanding was 242.78. The lowest was 80.17. And the median was 90.08.
OMER's Days Sales Outstanding is not ranked *
in the Biotechnology industry.
Industry Median: 72.245 * Ranked among companies with meaningful Days Sales Outstanding only.
Omeros's Days Sales Outstanding
stayed the same
from Dec. 2022 (0.00) to Dec. 2023 (0.00).
Omeros Days Sales Outstanding Historical Data
The historical data trend for Omeros's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Omeros's Days Sales Outstanding
For the Biotechnology subindustry, Omeros's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omeros's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Omeros's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Omeros's Days Sales Outstanding falls into.
Omeros Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Omeros (NAS:OMER) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Omeros Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Omeros's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The lead drug candidate in pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OMER has been successfully added to your 